Methotrexate (Page 8 of 8)

PACKAGE LABEL PRINCIPAL DISPLAY PANEL

NDC 0555-0572-35

Methotrexate Tablets, USP

2.5 mg

Caution: Cytotoxic Agent

PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient.

Rx only

36 Tablets

new
(click image for full-size original)
METHOTREXATE methotrexate tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0555-0572
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METHOTREXATE SODIUM (METHOTREXATE) METHOTREXATE 2.5 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
HYPROMELLOSES
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POLYETHYLENE GLYCOL, UNSPECIFIED
STARCH, CORN
PROPYLENE GLYCOL
SODIUM CARBONATE MONOHYDRATE
TALC
Product Characteristics
Color yellow Score 2 pieces
Shape OVAL Size 8mm
Flavor Imprint Code b;572
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0555-0572-35 36 TABLET in 1 BOTTLE None
2 NDC:0555-0572-02 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA081099 11/01/1990
Labeler — Teva Pharmaceuticals USA, Inc. (001627975)

Revised: 09/2020 Teva Pharmaceuticals USA, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.